Paul Michael Pronyk

Paul Michael Pronyk

Auto-generated profile, based on publicly available information

Paul Michael Pronyk

Duke-NUS Medical School, Centre for Outbreak Preparedness, Singapore, Singapore

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2023 in Cell Genomics
Verified
Journal Article
Open access
PPPaul Michael Pronyk
Paul Michael Pronyk
RARuklanthi de Alwis
Ruklanthi de Alwis
RRRebecca Rockett
Rebecca Rockett
KBKerri Basile
Kerri Basile
YBYann Felix Boucher
Yann Felix Boucher
VSVitali Sintchenko
Vitali Sintchenko
Genomic sequencing has emerged as a powerful tool to enhance early pathogen detection and characterization with implications for public health and clinical decision making. Although widely available in developed countries, the application of pathogen genomics among low-resource, high-disease burden settings remains at an early stage. In these contexts, tailored approaches for integrating pathogen genomics within infectious disease control programs will be essential to optimize cost efficiency and public health impact. We propose a framework for embedding pathogen genomics within national surveillance plans across a spectrum of surveillance and laboratory capacities. We adopt a public health approach to genomics and examine its application to high-priority diseases relevant in resource-limited settings. For each grouping, we assess the value proposition for genomics to inform public health and clinical decision-making, alongside its contribution toward research and development of novel diagnostics, therapeutics, and vaccines.

11 August 2022 in BMJ Open
Verified
Journal Article
Open access
PDF file
HJHafizah Jusril
Hafizah Jusril
CRCut Novianti Rachmi
Cut Novianti Rachmi
MAMohammad Ruhul Amin
Mohammad Ruhul Amin
MDMichelle Dynes
Michelle Dynes
VSVensya Sitohang
Vensya Sitohang
PPPaul M Pronyk
Paul M Pronyk
Objectives: Vaccine hesitancy remains a major barrier to immunisation coverage worldwide. We explored influence of hesitancy on coverage and factors contributing to vaccine uptake during a national measles–rubella (MR) campaign in Indonesia. Design: Secondary analyses of qualitative and quantitative data sets from existing cross-sectional studies conducted during and around the campaign. Methods: Quantitative data used in this assessment included daily coverage reports generated by health workers, district risk profiles that indicate precampaign immunisation programme performance, and reports of campaign cessation due to vaccine hesitancy. We used t-test and χ2 tests for associations. The qualitative assessment employed three parallel national and regional studies. Deductive thematic analysis examined factors for acceptance among caregivers, health providers and programme managers. Results: Coverage data were reported from 6462 health facilities across 395 districts from 1 August to 31 December 2018. The average district coverage was 73%, with wide variation between districts (2%–100%). One-third of districts fell below 70% coverage thresholds. Sixty-two of 395 (16%) districts paused the campaign due to hesitancy. Coverage among districts that never paused campaign activities due to hesitancy was significantly higher than rates for districts ever-pausing the campaign (81% vs 42%; p<0.001). Precampaign adequacy of district immunisation programmes did not explain coverage gaps (p=0.210). Qualitative analysis identified acceptance enablers including using digital health monitoring and feedback systems, increasing caregiver knowledge and awareness, making immunisation social norm, effective cross-sectoral collaboration, conducive service environment and positive experiences for mothers and children. Barriers included misinformation diffusion on social media, halal–haram issues, lack of healthcare provider knowledge, negative family influences and traditions, previous poor experiences and misinformation on adverse events. Conclusion: Barriers to vaccine uptake contributed to coverage gaps during national MR campaign in Indonesia. A range of supply-related and demand-related strategies were identified to address hesitancy contributors. Advancing a portfolio of tailored multilevel interventions will be critical to enhance vaccine acceptance.

21 April 2025 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
YSYafei Si
Yafei Si
LGLei Guo
Lei Guo
SCShu Chen
Shu Chen
XZXinyu Zhang
Xinyu Zhang
XDXiaochen Dai
Xiaochen Dai
STShenglan Tang
Shenglan Tang
Background: The Sustainable Development Goals (SDGs) articulate an ambitious global agenda and set of targets to achieve by 2030. Among the health-related SDGs, many formidable challenges remain in settings like the Association of Southeast Asian Nations (ASEAN) which face wide-ranging social, economic and health inequalities. In advance of the 2030 horizon, charting the trajectory of the health SDGs is critical for informing policy and programmatic course corrections to advance health and well-being among ASEAN’s 10 member countries with its 667 million people. Methods and findings: We used estimates from the Global Burden of Disease (GBD) Study 2021 and surveillance data to identify 27 health-related SDG indicators. The indicators were classified into 7 thematic areas: (i) nutrition, (ii) maternal, child and reproductive health (MCH), (iii) infectious diseases, (iv) non-communicable diseases (NCDs), (v) environmental health, (vi) universal health coverage (UHC), and (vii) road injuries. We developed an attainment index ranging from 0 to 100 for each SDG indicator by referencing the SDG targets and projected their progress to 2030. We find an overall positive progress towards the health-related SDG targets in ASEAN from 1990 to 2030. At the aggregate level by 2030, 2 member countries, Singapore and Brunei, are projected to achieve their targets (attainment score ≥ 90). At a wider regional level, ASEAN is projected to make substantial progress in nutrition, MCH, and UHC, with a majority of countries projected to come close to or achieve their targets. However, progress is projected to be slower in the areas of reducing the incidence of infectious disease (i.e., HIV and AIDs, hepatitis B, TB, and neglected tropical diseases), NCD-related mortality and its risk factors (i.e., harmful alcohol use and smoking), environment-related mortality and its risk factors (i.e., unsafe water and poor hygiene, and air pollution), and road injuries. Substantial disparities are identified in the region, with Singapore, Brunei, Malaysia and Thailand generally performing better than elsewhere. A limitation of our study was its reliance on historical trends which may not fully capture future political, social, or technological changes. Conclusions: As a regional bloc, ASEAN faces persistent challenges in achieving health-related SDG targets by 2030, with unequal progress between countries. Moreover, epidemiological transitions and worsening environmental threats further compound potential gains. At the country level, efforts to enhance health system financing, quality and equity will need to be coupled with wider approaches that address structural drivers of disease. Furthermore, coordinated regional efforts will be essential to effectively respond to emerging threats posed by pollution and environmental risks.

10 December 2020 in BMJ Open
Verified
Journal Article
Open access
PDF file
HJHafizah Jusril
Hafizah Jusril
IAIwan Ariawan
Iwan Ariawan
RDRita Damayanti
Rita Damayanti
LLLutfan Lazuardi
Lutfan Lazuardi
MMMiriam Musa
Miriam Musa
PMPatricia Mechael
Patricia Mechael
Objective: To assess the contribution of a digital health real-time monitoring platform towards the achievement of coverage targets during a national immunisation campaign in Indonesia. Interventions: A digital health platform was introduced to facilitate real-time reporting and data visualisation. Health workers submitted reports of children immunised each day by geolocation using mobile phones. Automated reports were generated for programme managers at all levels to enable early responses to coverage gaps. Methods: Risk profiles were generated for each district to assess precampaign immunisation programme performance. Digital health platform use and progress towards targets were monitored continuously throughout the campaign. Study outcomes were total coverage and time to achieve full (100%) coverage. Kaplan-Meier, Cox and linear regression analyses were used to estimate the associations and outcomes after adjusting for district risk profiles. A complementary qualitative assessment explored user experiences and acceptance through interviews with vaccinators and programme managers in provinces and districts selected through multistage random sampling. Results: Between August and December 2018, 6462 health facilities registered to use the digital health platform across 28 provinces and 395 districts. After adjusting for precampaign district risk profile and intracampaign delays due to vaccine hesitancy, districts with greater platform utilisation demonstrated higher coverage overall (R 2 =0.28, p75% reporting compliance; Risk Ratio 15.4, 95% CI 5.8 to 40.6). Stronger effects were observed among districts experiencing implementation delays due to vaccine hesitancy. Results from 106 key informant interviews conducted in 6 provinces and 18 districts suggest high degrees of acceptability, ease of use and satisfaction. Conclusion: A digital health platform introduced for real-time monitoring of a national immunisation campaign in Indonesia was feasible, well liked and associated with improved problem solving and programme performance, particularly among districts affected by vaccine hesitancy. Trial registration number: ISRCTN10850448 .

14 November 2024 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
HWHelene-Mari van der Westhuizen
Helene-Mari van der Westhuizen
SSSrinidhi Soundararajan
Srinidhi Soundararajan
TBTamsin Berry
Tamsin Berry
DADavid Agus
David Agus
SCSergio Carmona
Sergio Carmona
JBJohn Bell
John Bell

4 September 2026 in npj Digital Medicine
Verified
Journal Article
Open access
PDF file
MGMarya Getchell
Marya Getchell
MBMichael Barber
Michael Barber
TCThomas Carpino
Thomas Carpino
CSCarl J. E. Suster
Carl J. E. Suster
VSVitali Sintchenko
Vitali Sintchenko
PPPaul M. Pronyk
Paul M. Pronyk
Artificial intelligence (AI)-enabled infectious disease surveillance platforms are expanding rapidly, but their roles within health systems remain poorly characterized. This review examined 20 platforms according to primary data inputs, surveillance function, AI methods, data privacy, geographic scope and pathogen focus. Three archetypes emerged: Early Warning Networks, Situational Awareness Platforms and Integrated Surveillance Platforms. Their comparative analysis highlighted how data type, integration and localization shape platform contributions to public-health decision making.